Phase 1 Studies for Evaluating the Dermal Safety of Topical Products
This Webinar will provide an overview of required local tolerance studies. This includes methodological details as well as regulatory requirements.
While the local tolerance should be a prime concern for developing topical products successfully, this aspect is often neglected or addressed (too) late in the drug/medical device development. This webinar will provide a concise yet complete overview about required dermal safety studies and the respective protocol outlines, to evaluate cumulative irritation, contact sensitization, phototoxicity and photoallergy.
The webinar will take approximately 60 minutes and will end with a Q&A session.
